Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada
· Delayed Price · Currency is CAD 3.100
-0.070 (-2.26%)
Mar 9, 2026, 12:51 PM EST
Medexus Pharmaceuticals Ratios and Metrics
Market cap in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 100 | 78 | 39 | 32 | 63 | 151 | Upgrade
|
| Market Cap Growth | 3.82% | 98.25% | 21.95% | -48.46% | -58.62% | 335.06% | Upgrade
|
| Enterprise Value | 114 | 123 | 98 | 109 | 118 | 204 | Upgrade
|
| Last Close Price | 3.10 | 2.42 | 1.61 | 1.60 | 3.14 | 7.90 | Upgrade
|
| PE Ratio | - | 24.17 | - | 19.55 | - | - | Upgrade
|
| Forward PE | 7.43 | - | - | - | - | - | Upgrade
|
| PS Ratio | 0.73 | 0.50 | 0.26 | 0.22 | 0.65 | 1.51 | Upgrade
|
| PB Ratio | 1.40 | 1.04 | 0.96 | 1.06 | 2.82 | 6.68 | Upgrade
|
| P/FCF Ratio | 4.26 | 2.28 | 1.56 | - | - | 24.45 | Upgrade
|
| P/OCF Ratio | 4.21 | 2.26 | 1.55 | - | - | 23.88 | Upgrade
|
| EV/Sales Ratio | 0.84 | 0.79 | 0.64 | 0.74 | 1.23 | 2.04 | Upgrade
|
| EV/EBITDA Ratio | 6.13 | 4.53 | 3.91 | 5.59 | - | 25.52 | Upgrade
|
| EV/EBIT Ratio | 21.45 | 7.20 | 5.64 | 9.46 | - | 221.81 | Upgrade
|
| EV/FCF Ratio | 4.86 | 3.60 | 3.86 | - | - | 32.94 | Upgrade
|
| Debt / Equity Ratio | 0.49 | 0.71 | 1.65 | 3.12 | 3.08 | 2.49 | Upgrade
|
| Debt / EBITDA Ratio | 1.86 | 1.95 | 2.68 | 4.81 | - | 6.69 | Upgrade
|
| Debt / FCF Ratio | 1.48 | 1.56 | 2.67 | - | - | 9.12 | Upgrade
|
| Net Debt / Equity Ratio | 0.20 | 0.25 | 1.47 | 2.54 | 2.52 | 1.45 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.77 | 0.70 | 2.42 | 3.97 | -6.94 | 4.12 | Upgrade
|
| Net Debt / FCF Ratio | 0.61 | 0.55 | 2.39 | -37.88 | -35.12 | 5.32 | Upgrade
|
| Asset Turnover | 0.66 | 0.66 | 0.71 | 0.72 | 0.53 | 0.59 | Upgrade
|
| Inventory Turnover | 1.12 | 1.17 | 1.61 | 1.92 | 1.83 | 2.24 | Upgrade
|
| Quick Ratio | 0.43 | 0.38 | 0.44 | 0.43 | 0.51 | 0.94 | Upgrade
|
| Current Ratio | 1.12 | 0.83 | 1.10 | 0.87 | 1.02 | 1.47 | Upgrade
|
| Return on Equity (ROE) | -0.64% | 5.45% | -0.81% | 6.07% | -16.08% | -133.66% | Upgrade
|
| Return on Assets (ROA) | 1.62% | 4.55% | 5.04% | 3.53% | -5.38% | 0.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.14% | 16.99% | -33.43% | 11.95% | -23.17% | 1.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.20% | 16.00% | 14.30% | 10.90% | -13.60% | 0.70% | Upgrade
|
| Earnings Yield | -0.37% | 4.14% | -0.74% | 5.12% | -5.74% | -23.48% | Upgrade
|
| FCF Yield | 23.50% | 43.91% | 64.18% | -6.31% | -2.54% | 4.09% | Upgrade
|
| Buyback Yield / Dilution | -28.99% | -18.76% | -8.76% | -3.36% | -30.65% | -5.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.